Search results
Fauci, other top health officials receive Moderna Covid-19 vaccine on camera
AOL· 43 minutes agoFauci, director of the National Institute of Allergy and Infectious Diseases, received the shot...
How mRNA vaccines could be personalized cancer cures
Axios· 3 hours agoWhy it matters: This personalized approach could make conditions like melanoma and bladder, kidney, pancreatic and breast cancers treatable, and even...
Tech Bytes: Moderna partners with OpenAI to expedite drug development processes
Proactive Investors· 7 hours agoModerna, the biotechnology firm best known for its COVID-19 vaccines, has partnered with artificial...
Moderna Q1 earnings: lower-than-expected loss of $1.18 billion sets tone for vaccine launch | Invezz
Invezz· 5 days agoModerna Inc (NASDAQ: MRNA) reported a narrower-than-expected loss for the first quarter of the year,...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 5 days agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 5 days agoModerna’s next focus is to continue rolling out mRNA vaccines, which teaches cells how to make the...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 4 days agoNet product sales plummeted by 91% compared to Q1 2023. This downturn aligns with the expected transition to a seasonal market for Covid-19 vaccines....
Moderna (NASDAQ:MRNA) PT Raised to $106.00
ETF DAILY NEWS· 11 hours agoModerna (NASDAQ:MRNA – Free Report) had its price target increased by Canaccord Genuity Group from $91.00 to $106.00 in a report published on Friday, Benzinga reports. Canaccord ...
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 4 days agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 5 days agoA Food and Drug Administration decision on approval of Moderna’s RSV vaccine is expected by May 12,...